scholarly journals Investigation of the effects of fetal rat kidney-derived mesenchymal stem cells implementation on doxorubicin-induced nephropathy in male Sprague – dawley rats

Author(s):  
Başak BOZTOK ÖZGERMEN ◽  
Gaye BULUT ◽  
Ferda ALPASLAN PINARLI ◽  
Salih Sinan GÜLTEKİN ◽  
Doğukan ÖZEN ◽  
...  
2016 ◽  
Vol 7 (1) ◽  
Author(s):  
Rehab H. Ashour ◽  
Mohamed-Ahdy Saad ◽  
Mohamed-Ahmed Sobh ◽  
Fatma Al-Husseiny ◽  
Mohamed Abouelkheir ◽  
...  

2016 ◽  
Vol 9 (1) ◽  
pp. 70-78 ◽  
Author(s):  
Fatma Al-Husseiny ◽  
Mohamed Ahmed Sobh ◽  
Rehab H. Ashour ◽  
Samah Foud ◽  
Tarek Medhat ◽  
...  

2008 ◽  
Vol 17 (10-11) ◽  
pp. 1157-1167 ◽  
Author(s):  
Alberto Magnasco ◽  
Mirko Corselli ◽  
Roberta Bertelli ◽  
Adalberto Ibatici ◽  
Monica Peresi ◽  
...  

Mesenchymal stem cells (MSCs) may be of value in regeneration of renal tissue after damage; however, lack of biological knowledge and variability of results in animal models limit their utilization. We studied the effects of MSCs on podocytes in vitro and in vivo utilizing adriamycin (ADR) as a model of renal toxicity. The in vivo experimental approach was carried out in male Sprague-Dawley rats (overall 60 animals) treated with different ADR schemes to induce acute and chronic nephrosis. MSCs were given a) concomitantly to ADR in tail vein or b) in aorta and c) in tail vein 60 days after ADR. Homing was assessed with PKH26-MSCs. MSCs rescued podocytes from apoptosis induced by ADR in vitro. The maximal effect (80% rescue) was obtained with MSCs/podocytes coculture ratio of 1:1 for 72 h. All rats treated with ADR developed nephrosis. MSCs did not modify the clinical parameters (i.e., proteinuria, serum creatinine, lipids) but protected the kidney from severe glomerulosclerosis when given concomitantly to ADR. Rats given MSCs 60 days after ADR developed the same severe renal damage. Only a few MSCs were found in renal tubule-interstitial areas 1–24 h after injection and no MSCs were detected in glomeruli. MSCs reduced apoptosis of podocytes treated with ADR in vitro. Early and repeated MSCs infusion blunted glomerular damage in chronic ADR-induced nephropathy. MSCs did not modify proteinuria and progression to renal failure, which implies lack of regenerative potential in this model.


2021 ◽  
Vol 13 (2) ◽  
pp. 623-631
Author(s):  
Gang‐qiang Du ◽  
Zhi‐hao Gong ◽  
Bin Liang ◽  
Peng Li ◽  
Shu‐ye Yang ◽  
...  

2016 ◽  
Vol 9 (1) ◽  
pp. 79-89 ◽  
Author(s):  
Fatma E Moustafa ◽  
Mohamed-A Sobh ◽  
Mohamed Abouelkheir ◽  
Youmna Khater ◽  
Khalid Mahmoud ◽  
...  

2016 ◽  
Vol 94 (9) ◽  
pp. 936-946 ◽  
Author(s):  
Abdelaziz M. Hussein ◽  
Nashwa Barakat ◽  
Amira Awadalla ◽  
Mahmoud M. Gabr ◽  
Sherry Khater ◽  
...  

The present study investigated the effects of combination of ischemic preconditioning (Ipre) and adipose-derived mesenchymal stem cells (ADMSCs) on renal ischemia–reperfusion (I–R) injury in rats. 90 male Sprague Dawley rats were divided into 5 equal groups; sham operated, control (45 min left renal ischemia), Ipre group as control group with 3 cycles of Ipre just before renal ischemia, ADMSCs-treated group (as control with ADMSCs 106 cells in 0.1 mL via penile vein 60 min before ischemia time), and Ipre + ADMSCs group as ADMCs group with 3 cycles of Ipre. Ipre and ADMSCs groups showed significant decrease in serum creatinine and blood urea nitrogen (BUN) and caspase-3 and CD45 expression in kidney and significant increase in HIF-1α, SDF-1α, CD31, and Ki67 expressions in kidney compared with the control group (p < 0.05). Moreover, the Ipre + ADMSCs group showed significant decrease in serum BUN and caspase-3 and CD45 expression in kidney with significant increase in HIF-1α, SDF-1α, CD31, and Ki67 expression in kidney compared with the Ipre and ADMCs groups (p < 0.05). We concluded that Ipre potentiates the renoprotective effect of ADMSCs against renal I/R injury probably by upregulation of HIF-1α, SDF-1α, CD31, and Ki67 and downregulation of caspase-3 and CD45.


2020 ◽  
Vol 21 (4) ◽  
pp. 1272 ◽  
Author(s):  
Hyeongseop Kim ◽  
Duk L. Na ◽  
Na Kyung Lee ◽  
A Ran Kim ◽  
Seunghoon Lee ◽  
...  

Mesenchymal stem cells (MSCs) are considered as promising therapeutic agents for neurodegenerative disorders because they can reduce underlying pathology and also repair damaged tissues. Regarding the delivery of MSCs into the brain, intravenous and intra-arterial routes may be less feasible than intraparenchymal and intracerebroventricular routes due to the blood–brain barrier. Compared to the intraparenchymal or intracerebroventricular routes, however, the intrathecal route may have advantages: this route can deliver MSCs throughout the entire neuraxis and it is less invasive since brain surgery is not required. The objective of this study was to investigate the distribution of human Wharton’s jelly-derived MSCs (WJ-MSCs) injected via the intrathecal route in a rat model. WJ-MSCs (1 × 106) were intrathecally injected via the L2-3 intervertebral space in 6-week-old Sprague Dawley rats. These rats were then sacrificed at varying time points: 0, 6, and 12 h following injection. At 12 h, a significant number of MSCs were detected in the brain but not in other organs. Furthermore, with a 10-fold higher dose of WJ-MSCs, there was a substantial increase in the number of cells migrating to the brain. These results suggest that the intrathecal route can be a promising route for the performance of stem cell therapy for CNS diseases.


Sign in / Sign up

Export Citation Format

Share Document